DocDollars

Adc Therapeutics America, Inc.

NJ · United States · Reporting entity ID 100000961860

Total reported 2019–2025
$18.3M
#344 of 2,960 reporting companies — 0% of all reported industry payments
$4.42M in general payments across 16,138 records, plus $13.8M in research funding across 2,897 records.

How it breaks down

General payments $4,422,035
Research funding $13,838,629

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Adc Therapeutics America, Inc. reported $18.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #344 of 2,960 reporting companies. 76% of that was research funding and 24% general payments such as consulting, speaking, food and travel. 16,138 general payment records and 2,897 research records were filed.

Common questions about Adc Therapeutics America, Inc.

How much has Adc Therapeutics America, Inc. paid US doctors?

Adc Therapeutics America, Inc. reported $18,260,664 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $4,422,035 in general payments, $13,838,629 in research funding.

How does Adc Therapeutics America, Inc. rank among drug and device companies?

It ranks #344 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Adc Therapeutics America, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.